Uniform Controlled Substances Act; include five substances in Schedule I.

H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~ G1/2
26/HR43/R1500
PAGE 1 (MCL\KP)

To: Drug Policy
MISSISSIPPI LEGISLATURE REGULAR SESSION 2026

By: Representative Waldo

HOUSE BILL NO. 417

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, 1
TO INCLUDE FIVE SUBSTANCES AS SCHEDULE I CONTROLLED SUBSTANCES 2
BECAUSE THESE DRUGS HAVE NO LEGITIMATE MEDICAL USE AND HAVE A HIGH 3
POTENCY WITH GREAT POTENTIAL TO CAUSE HARM; AND FOR RELATED 4
PURPOSES. 5
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: 6
SECTION 1. Section 41-29-113, Mississippi Code of 1972, is 7
amended as follows: 8
41-29-113. 9
SCHEDULE I 10
(a) Schedule I consists of the drugs and other substances, 11
by whatever official name, common or usual name, chemical name, or 12
brand name designated, that is listed in this section. 13
(b) Opiates. Unless specifically excepted or unless listed 14
in another schedule, any of the following opiates, including their 15
isomers, esters, ethers, salts and salts of isomers, esters and 16
ethers, whenever the existence of these isomers, esters, ethers 17
and salts is possible within the specific chemical designation: 18
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 2 (MCL\KP)

(1) Acetyl-alpha-methylfentanyl 19
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); 20
(2) Acetylmethadol; 21
(3) Acetyl fentanyl 22
(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 23
(4) Acryl fentanyl 24
(N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide), also known as 25
acryloylfentanyl; 26
(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) 27
cyclohexylmethyl]benzamide); 28
(6) Allylprodine; 29
(7) Alphacetylmethadol, except levo-alphacetylmethadol 30
(levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM); 31
(8) Alphameprodine; 32
(9) Alphamethadol; 33
(10) Alpha′-methyl butyryl fentanyl 34
(2-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 35
(11) Alpha-Methylfentanyl 36
(N-[1-alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 37
1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine); 38
(12) Alpha-Methylthiofentanyl 39
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide40
); 41
(13) Benzethidine; 42
(14) Betacetylmethadol; 43
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 3 (MCL\KP)

(15) Beta-Hydroxyfentanyl 44
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); 45
(16) Beta-Hydroxy-3-methylfentanyl 46
(N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpr47
opanamide); 48
(17) Beta-Hydroxythiofentanyl 49
(N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpr50
opionamide); 51
(18) Betameprodine; 52
(19) Betamethadol; 53
(20) Beta-Methyl fentanyl 54
(N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide), also 55
known as β-methyl fentanyl; 56
(21) Beta'-Phenyl fentanyl 57
(N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide), also 58
known as β'-phenyl fentanyl or 3-phenylpropanoyl fentanyl; 59
(22) Betaprodine; 60
(23) Brorphine (1–(1–(1–61
(4-bromophenyl)ethyl)piperidin-4–yl)–62
1,3-dihydro-2H-benzo[d]imidazol-2-one); 63
(24) Butyrl fentanyl 64
(N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); 65
(25) Clonitazene; 66
(26) Crotonyl fentanyl 67
((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide); 68
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 4 (MCL\KP)

(27) Cyclopentyl fentanyl 69
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide); 70
(28) Cyclopropyl fentanyl 71
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide); 72
(29) Dextromoramide; 73
(30) Diampromide; 74
(31) Diethylthiambutene; 75
(32) Difenoxin; 76
(33) Dimenoxadol; 77
(34) Dimepheptanol; 78
(35) 2′,5′-dimethoxyfentanyl 79
(N-1-2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide); 80
(36) Dimethylthiambutene; 81
(37) Dioxaphetyl butyrate; 82
(38) Dipipanone; 83
(39) Ethylmethylthiambutene; 84
(40) Etodesnitazene 85
(2-2-4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amin86
e, also known as etazene; 87
(41) Etonitazene; 88
(42) Etoxeridine; 89
(43) Fentanyl carbamate 90
(ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate); 91
(44) Fentanyl-related substances, meaning any substance 92
not otherwise listed under another schedule and for which no 93
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 5 (MCL\KP)

exemption or approval is in effect under Section 505 of the 94
Federal Food, Drug, and Cosmetic Act [21 USC 355] that is 95
structurally related to fentanyl by one or more of the following 96
modifications: 97
(A) Replacement of the phenyl portion of the 98
phenethyl group by any monocycle, whether or not further 99
substituted in or on the monocycle; 100
(B) Substitution in or on the phenethyl group with 101
alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro 102
groups; 103
(C) Substitution in or on the piperidine ring with 104
alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, 105
amino or nitro groups; 106
(D) Replacement of the aniline ring with any 107
aromatic monocycle whether or not further substituted in or on the 108
aromatic monocycle; and/or 109
(E) Replacement of the N-propionyl group by 110
another acyl group. 111
(45) 4-Fluoroisobutyryl fentanyl 112
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide), 113
also known as para-fluoroisobutyryl fentanyl); 114
(46) 2'-Fluoro ortho-fluorofentanyl 115
(N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl) 116
propionamide), also known as 2'-fluoro 2-fluorofentanyl; 117
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 6 (MCL\KP)

(47) Furanyl fentanyl 118
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide); 119
(48) 3-furanyl fentanyl 120
(N-1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide); 121
(49) Furethidine; 122
(50) Hydroxypethidine; 123
(51) Isobutyryl fentanyl 124
(N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide); 125
(52) Isotonitazene (N,N-diethyl-2-(2-(4 126
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine); 127
(53) Isovaleryl fentanyl 128
(3-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 129
(54) Ketobemidone (including the optical and geometric 130
isomers); 131
(55) Levomoramide; 132
(56) Levophenacylmorphan; 133
(57) Meta-fluorofentanyl 134
(N-3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide); 135
(58) Meta-fluoroisobutyryl fentanyl 136
(N-(3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)isobutyramide); 137
(59) Methoxyacetyl fentanyl 138
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 139
(60) 4'-Methyl acetyl fentanyl 140
(N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide); 141
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 7 (MCL\KP)

(61) 2-methyl AP–237 142
(1-2-methyl-4-3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one; 143
(62) 3-Methylfentanyl 144
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); 145
(63) 3-Methylthiofentanyl (N-[3-methyl-1- 146
(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide); 147
(64) Para-methoxyfuranyl fentanyl 148
(N-(4-methoxyphenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxami149
de); 150
(65) Metonitazene 151
(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)e152
than-1-amine (metonitazene); 153
(66) Morpheridine; 154
(67) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); 155
(68) MT-45 156
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine); 157
(69) N-pyrrolidino etonitazene 158
2-4-ethoxybenzyl)-5-nitro-1-2-pyrrolidin-1-yl)ethyl)-1H-benzimidaz159
ole, also known as etonitazepyne; 160
(70) Noracymethadol; 161
(71) Norlevorphanol; 162
(72) Normethadone; 163
(73) Norpipanone; 164
(74) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N- 165
(1-phenethylpiperidin-4-yl)acetamide); 166
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 8 (MCL\KP)

(75) Ortho-Fluoroacryl fentanyl 167
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide); 168
(76) Ortho-Fluorobutyryl fentanyl 169
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide), also 170
known as 2-fluorobutyryl fentanyl; 171
(77) Ortho-Fluorofentanyl 172
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 173
also known as 2-fluorofentanyl; 174
(78) Ortho-fluorofuranyl fentanyl 175
(N-2-fluorophenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide176
); 177
(79) Ortho-Fluoroisobutyryl fentanyl 178
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 179
(80) Ortho-Methyl acetylfentanyl 180
(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide), also 181
known as 2-methyl acetylfentanyl; 182
(81) Ortho-Methyl methoxyacetyl fentanyl 183
(2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) 184
acetamide), also known as 2-methyl methoxyacetyl fentanyl; 185
(82) Para-Chloroisobutyryl fentanyl 186
(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 187
(83) Para-Fluorobutyryl fentanyl 188
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 189
(84) Para-Fluorofentanyl (N-(4-fluorophenyl) 190
-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide); 191
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 9 (MCL\KP)

(85) Para-Fluoro furanyl fentanyl N-(4-fluorophenyl)-N- 192
(1-phenethylpiperidin-4-yl)furan-2-carboxamide); 193
(86) Para-Methoxybutyryl fentanyl 194
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 195
(87) Para-methylcyclopropyl fentanyl 196
(N-4-methylphenyl)-N-1-phenethylpiperidin-4-yl)cyclopropanecarboxa197
mide); 198
(88) Para-Methylfentanyl 199
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 200
also known as 4-methylfentanyl); 201
(89) PEPAP 202
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine); 203
(90) Phenadoxone; 204
(91) Phenampromide; 205
(92) Phenomorphan; 206
(93) Phenoperidine; 207
(94) Phenyl fentanyl 208
(N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide), also known as 209
benzoyl fentanyl; 210
(95) Piritramide; 211
(96) Proheptazine; 212
(97) Properidine; 213
(98) Propiram; 214
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 10 (MCL\KP)

(99) Protonitazene 215
N,N-diethyl-2-5-nitro-2-4-propoxybenzyl)-1H-benzimidazol-1-yl)etha216
n-1-amine; 217
(100) Racemoramide; 218
(101) Tetrahydrofuranyl fentanyl 219
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2- 220
carboxamide); 221
(102) Thiofentanyl 222
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide); 223
(103) Thiofuranyl fentanyl 224
(N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide), 225
also known as 2-thiofuranyl fentanyl or thiophene fentanyl; 226
(104) Tilidine; 227
(105) Trimeperidine; 228
(106) U-47700, (3,4-dichloro-N- 229
[2-(dimethylamino)cyclohexyl]-N-methylbenzamide); 230
(107) Valeryl fentanyl 231
(N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) * * *; 232
(108) Butonitazene 233
(2-2-4-butoxybenzyl)-5-nitro-1H-benzimidazol1-yl)-N,N-diethylethan234
-1-amine); 235
(109) Flunitazene 236
(N,N-diethyl-2-2-4-fluorobenzyl)-5-nitro-1H-benzimidazol1-yl)ethan237
-1-amime); 238
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 11 (MCL\KP)

(110) Metodesnitazene 239
(N,N-diethyl-2-2-4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-ami240
ne). 241
(c) Opium derivatives. Unless specifically excepted or 242
unless listed in another schedule, any of the following opium 243
derivatives, their salts, isomers and salts of isomers, whenever 244
the existence of these salts, isomers and salts of isomers is 245
possible within the specific chemical designation: 246
(1) Acetorphine; 247
(2) Acetyldihydrocodeine; 248
(3) Benzylmorphine; 249
(4) Codeine methylbromide; 250
(5) Codeine-N-Oxide; 251
(6) Cyprenorphine; 252
(7) Desomorphine; 253
(8) Dihydromorphine; 254
(9) Drotebanol; 255
(10) Etorphine (except hydrochloride salt); 256
(11) Heroin; 257
(12) Hydromorphinol; 258
(13) Methyldesorphine; 259
(14) Methyldihydromorphine; 260
(15) Monoacetylmorphine; 261
(16) Morphine methylbromide; 262
(17) Morphine methylsulfonate; 263
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 12 (MCL\KP)

(18) Morphine-N-Oxide; 264
(19) Myrophine; 265
(20) Nicocodeine; 266
(21) Nicomorphine; 267
(22) Normorphine; 268
(23) Pholcodine; 269
(24) Thebacon. 270
(d) Hallucinogenic substances. Unless specifically excepted 271
or unless listed in another schedule, any material, compound, 272
mixture or preparation which contains any quantity of the 273
following substances, their salts, isomers (whether optical, 274
positional, or geometric) and salts of isomers, whenever the 275
existence of these salts, isomers and salts of isomers is possible 276
within the specific chemical designation: 277
(1) Alpha-ethyltryptamine; 278
(2) 4-bromo-2,5-dimethoxy-amphetamine; 279
(3) 4-bromo-2,5-dimethoxyphenethylamine; 280
(4) 2,5-dimethoxyamphetamine; 281
(5) 2,5-dimethoxy-4-ethylamphetamine (DOET); 282
(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine 283
(2C-T-7); 284
(7) 4-methoxyamphetamine; 285
(8) 5-methoxy-3,4-methylenedioxy-amphetamine; 286
(9) 4-methyl-2,5-dimethoxy-amphetamine; 287
(10) 3,4-methylenedioxy amphetamine; 288
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 13 (MCL\KP)

(11) 3,4-methylenedioxymethamphetamine (MDMA); 289
(12) 3,4-methylenedioxy-N-ethylamphetamine (also known 290
as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl 291
MDA, MDE, MDEA); 292
(13) N-hydroxy-3,4-methylenedioxyamphetamine (also 293
known as N-hydroxy MDA, N-OHMDA, and 294
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine); 295
(14) 3,4,5-trimethoxy amphetamine; 296
(15) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT); 297
(16) Alpha-methyltryptamine (also known as AMT); 298
(17) Bufotenine; 299
(18) Diethyltryptamine; 300
(19) Dimethyltryptamine; 301
(20) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT); 302
(21) Ibogaine; 303
(22) Lysergic acid diethylamide (LSD); 304
(23) (A) Marijuana (Hemp as defined and regulated 305
under Sections 69-25-201 through 69-25-221 and Cannabidiol 306
contained in a legend drug product approved by the Federal Food 307
and Drug Administration or obtained under Section 41-29-136 are 308
exempt under Schedule I); 309
(B) Hashish; 310
(24) Mescaline; 311
(25) Parahexyl; 312
(26) Peyote; 313
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 14 (MCL\KP)

(27) N-ethyl-3-piperidyl benzilate; 314
(28) N-methyl-3-piperidyl benzilate; 315
(29) Psilocybin; 316
(30) Psilocyn; 317
(31) Tetrahydrocannabinols, meaning 318
tetrahydrocannabinols contained in a plant of the genus Cannabis 319
(cannabis plant), as well as the synthetic equivalents of the 320
substances contained in the cannabis plant, or in the resinous 321
extractives of such plant, and/or synthetic substances, 322
derivatives, and their isomers with similar chemical structure and 323
pharmacological activity to those substances contained in the 324
plant such as the following: 325
(A) 1 cis or trans tetrahydrocannabinol; 326
(B) 6 cis or trans tetrahydrocannabinol; 327
(C) 3,4 cis or trans tetrahydrocannabinol. 328
(Since nomenclature of these substances is not 329
internationally standardized, compounds of these structures, 330
regardless of atomic positions, are covered.) 331
("Tetrahydrocannabinols" excludes dronabinol and nabilone.) 332
For purposes of this paragraph, tetrahydrocannabinols do not 333
include hemp or hemp products regulated under Sections 69-25-201 334
through 69-25-221. 335
However, the following products are exempted from control: 336
(i) THC-containing industrial products made 337
from cannabis stalks (e.g., paper, rope and clothing); 338
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 15 (MCL\KP)

(ii) Processed cannabis plant materials used 339
for industrial purposes, such as fiber retted from cannabis stalks 340
for use in manufacturing textiles or rope; 341
(iii) Animal feed mixtures that contain 342
sterilized cannabis seeds and other ingredients (not derived from 343
the cannabis plant) in a formula designed, marketed and 344
distributed for nonhuman consumption; 345
(iv) Personal care products that contain oil 346
from sterilized cannabis seeds, such as shampoos, soaps, and body 347
lotions (if the products do not cause THC to enter the human 348
body); 349
(v) Hemp as regulated under Sections 350
69-25-201 through 69-25-221; and 351
(vi) Any product derived from the hemp plant 352
designed for human ingestion and/or consumption that is approved 353
by the United States Food and Drug Administration; 354
(32) Phencyclidine; 355
(33) Ethylamine analog of phencyclidine (PCE); 356
(34) Pyrrolidine analog of phencyclidine (PHP, PCPy); 357
(35) Thiophene analog of phencyclidine; 358
(36) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy); 359
(37) 4-methylmethcathinone (mephedrone); 360
(38) 3,4-methylenedioxypyrovalerone (MDPV); 361
(39) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine (2C-E); 362
(40) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D); 363
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 16 (MCL\KP)

(41) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); 364
(42) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); 365
or 2,5-dimethoxy-4-iodophenethylamine; 366
(43) 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine 367
(2C-T-2); 368
(44) 369
2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4); 370
(45) 2-(2,5-dimethoxyphenyl)ethanamine (2C-H); 371
(46) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine (2C-N); 372
(47) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine 373
(2C-P); 374
(48) 3,4-methylenedioxy-N-methylcathinone(methylone); 375
(49) 376
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 377
(25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36); 378
(50) 379
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 380
(25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82); 381
(51) 382
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or 383
N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; 384
Cimbi-5); 385
(52) 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1, 386
4-benzodiazepin-2-one (also known as Phenazepam); 387
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 17 (MCL\KP)

(53) 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8, 388
11,12-tetraazatricyclo[8.3.0.0]trideca-2(6),4,7,10,12-pentaene 389
(also known as Etizolam); 390
(54) Salvia divinorum; 391
(55) Synthetic cannabinoids. Unless specifically 392
excepted or unless listed in another schedule, any material, 393
compound, mixture, or preparation which contains any quantity of a 394
synthetic cannabinoid found in any of the following chemical 395
groups, whether or not substituted to any extent, or any of those 396
groups which contain any synthetic cannabinoid salts, isomers, or 397
salts of isomers, whenever the existence of such salts, isomers, 398
or salts of isomers is possible within the specific chemical 399
designation, including all synthetic cannabinoid chemical 400
analogues in such groups: 401
(A) (6aR,10aR)-9-(hydroxymethyl)-6, 402
6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] 403
chromen-1-ol (also known as HU-210 or 404
1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol); 405
(B) Naphthoylindoles and naphthylmethylindoles, 406
being any compound structurally derived from 3-(1-naphthoyl)indole 407
or 1H-indol-3-yl-(1-naphthyl)methane, whether or not substituted 408
in the indole ring to any extent, or in the naphthyl ring to any 409
extent; 410
(C) Naphthoylpyrroles, being any compound 411
structurally derived from 3-(1-naphthoyl)pyrrole, whether or not 412
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 18 (MCL\KP)

substituted in the pyrrole ring to any extent, or in the naphthyl 413
ring to any extent; 414
(D) Naphthylmethylindenes, being any compound 415
structurally derived from 1-(1-naphthylmethyl)indene, whether or 416
not substituted in the indene ring to any extent or in the 417
naphthyl ring to any extent; 418
(E) Phenylacetylindoles, being any compound 419
structurally derived from 3-phenylacetylindole, whether or not 420
substituted in the indole ring to any extent or in the phenyl ring 421
to any extent; 422
(F) Cyclohexylphenols, being any compound 423
structurally derived from 2-(3-hydroxycyclohexyl)phenol, whether 424
or not substituted in the cyclohexyl ring to any extent or in the 425
phenolic ring to any extent; 426
(G) Benzoylindoles, whether or not substituted in 427
the indole ring to any extent or in the phenyl ring to any extent; 428
(H) Adamantoylindoles, whether or not substituted 429
in the indole ring to any extent or in the adamantoyl ring system 430
to any extent; 431
(I) Tetrahydro derivatives of cannabinol and 432
3-alkyl homologues of cannabinol or of its tetrahydro derivatives, 433
except where contained in cannabis or cannabis resin; 434
(J) 3-Cyclopropylmethanone indole or 435
3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by 436
substitution at the nitrogen atom of the indole ring, whether or 437
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 19 (MCL\KP)

not further substituted in the indole ring to any extent, whether 438
or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl 439
rings to any extent; 440
(K) Quinolinyl ester indoles, being any compound 441
structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl 442
ester, whether or not substituted in the indole ring to any extent 443
or the quinolone ring to any extent; 444
(L) 3-carboxamide-1H-indazoles, whether or not 445
substituted in the indazole ring to any extent and substituted to 446
any degree on the carboxamide nitrogen and 447
3-carboxamide-1H-indoles, whether or not substituted in the indole 448
ring to any extent and substituted to any degree on the 449
carboxamide nitrogen; 450
(M) Cycloalkanemethanone Indoles, whether or not 451
substituted at the nitrogen atom on the indole ring, whether or 452
not further substituted in the indole ring to any extent, whether 453
or not substituted on the cycloalkane ring to any extent; 454
(56) Naphthalen-1-yl 455
1-(5-fluoropentyl)-1H-indole-3-carboxylate, also known as NM2201 456
or CBL2201; 457
(57) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- 458
pyrrolo[2,3-b]pyridine-3-carboxamide, also known as 459
5F-CUMYL-P7AICA or SGT-25; 460
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 20 (MCL\KP)

(58) Methyl 461
2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutano462
ate, also known as 4F-MDMB-BINACA or 4F-MDMB-BUTINACA); 463
(59) 1-(4-methoxyphenyl)-N-methylpropan-2-amine, also 464
known as para-methoxymethamphetamine or PMMA; 465
(60) Ethyl 2-(1-(5-fluoropentyl) 466
-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, also known as 467
5F-EDMB-PINACA; 468
(61) Methyl 469
2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoa470
te, also known as 5F-MDMB-PICA or 5F-MDMB-2201; 471
(62) 472
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, 473
also known as FUB-AKB48 or FUB-APINACA or AKB48 474
N-(4-fluorobenzyl); 475
(63) 476
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)477
methanone, also known as FUB-144; 478
(64) N-ethylhexedrone, also known as 479
α-ethylaminohexanophenone or 2-(ethylamino)-1-phenylhexan-1-one; 480
(65) Alpha-pyrrolidinohexanophenone, also known as 481
α-PHP or α-pyrrolidinohexanophenone or 482
1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one); 483
(66) 4-methyl-alpha-ethylaminopentiophenone, also known 484
as 4-MEAP or 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one); 485
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 21 (MCL\KP)

(67) 4'-methyl-alpha-pyrrolidinohexiophenone, also 486
known as MPHP or 4'-methyl-alpha-pyrrolidinohexanophenone or 487
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one); 488
(68) Alpha-pyrrolidinoheptaphenone (also known as PV8; 489
1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one); 490
(69) 4'-chloro-alpha-pyrrolidinovalerophenone, also 491
known as 4-chloro-α-PVP or 4'-chloro-α-pyrrolidinopentiophenone or 492
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one); 493
(70) 494
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one, also known as 495
methoxetamine or MXE; 496
(71) Zipeprol 497
(1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylp498
ropan-2-ol); 499
(72) Eutylone 500
(1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one); * * * 501
(73) ADB–BUTINACA 502
N-1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carb503
oxamide * * *; 504
(74) 505
1-1,3-benzodioxol-5-yl)-2-dimethylamino)pentan-1-one(dipentylone; 506
N,N-dimethylpentylone). 507
(e) Depressants. Unless specifically excepted or unless 508
listed in another schedule, any material, compound, mixture, or 509
preparation which contains any quantity of the following 510
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 22 (MCL\KP)

substances having a depressant effect on the central nervous 511
system, including their salts, isomers, and salts of isomers, 512
whenever the existence of such salts, isomers, and salts of 513
isomers is possible within the specific chemical designation: 514
(1) Clonazolam, 515
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]516
benzodiazepine; 517
(2) Flualprazolam, 518
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4519
]benzodiazepine; 520
(3) Flubromazepam, 521
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 522
(4) Flubromazolam, 523
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]524
benzodiazepin; 525
(5) Gamma-hydroxybutyric acid (other names include: 526
GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic 527
acid; sodium oxybate; sodium oxybutyrate); 528
(6) Mecloqualone; 529
(7) Methaqualone. 530
(f) Stimulants. Any material, compound, mixture or 531
preparation which contains any quantity of the following central 532
nervous system stimulants including optical salts, isomers and 533
salts of isomers unless specifically excepted or unless listed in 534
another schedule: 535
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 23 (MCL\KP)

(1) Aminorex; 536
(2) Amineptine 537
(7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic 538
acid); 539
(3) N-benzylpiperazine (also known as BZP and 540
1-benzylpiperazine); 541
(4) Cathinone; 542
(5) 4,4'-Dimethylaminorex, also known as 4,4'-DMAR or 543
4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 544
4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine); 545
(6) Fenethylline; 546
(7) Mesocarb 547
(N-phenyl-N' -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3- 548
ium-5-yl)carbamimidate); 549
(8) Methcathinone; 550
(9) Methiopropamine 551
(N-methyl-1-(thiophen-2-yl)propan-2-amine)); 552
(10) 4-methylaminorex (also known as 553
2-amino-4-methyl-5-phenyl-2-oxazoline); 554
(11) N-ethylamphetamine; 555
(12) Any material, compound, mixture or preparation 556
which contains any quantity of N,N-dimethylamphetamine. (Other 557
names include: N,N,-alpha-trimethyl-benzeneethanamine and 558
N,N-alpha-trimethylphenethylamine); 559
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 24 (MCL\KP)

(13) Synthetic cathinones. (A) Unless listed in 560
another schedule, any compound other than bupropion that is 561
structurally derived from 2-Amino-1-phenyl-1-propanone by 562
modification in any of the following ways: 563
(i) By substitution in the phenyl ring to any 564
extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide 565
substituents, whether or not further substituted in the phenyl 566
ring by one or more other univalent substituents; 567
(ii) By substitution at the 3-position with 568
an alkyl substituent; 569
(iii) By substitution at the nitrogen atom 570
with alkyl or dialkyl groups, or by inclusion of the nitrogen atom 571
in a cyclic structure. 572
(B) The compounds covered in this paragraph (10) 573
include, but are not limited to, any material, compound, mixture 574
or preparation which contains any quantity of a synthetic 575
cathinone found in any of the following compounds, whether or not 576
substituted to any extent, or any of these compounds which contain 577
any synthetic cathinone, or salts, isomers, or salts of isomers, 578
whenever the existence of such salts, isomers or salts of isomers 579
is possible, unless specifically excepted or listed in another 580
schedule: 581
(i) 4-methyl-N-ethylcathinone ("4-MEC"); 582
(ii) 4-methyl-alpha-pyrrolidinopropiophenone 583
("4-MePPP"); 584
H. B. No. 417 *HR43/R1500* ~ OFFICIAL ~
26/HR43/R1500
PAGE 25 (MCL\KP)
ST: Uniform Controlled Substances Act; include
five substances in Schedule I.
(iii) Alpha-pyrrolidinopentiophenone 585
("α-PVP"); 586
(iv) 1-(1,3-benzodioxol-5-yl)-2- 587
(methylamino)butan-1-one ("butylone"); 588
(v) 2-(methylamino)-1-phenylpentan-1-one 589
("pentedrone"); 590
(vi) 1-(1,3-benzodioxol-5-yl)-2- 591
(methylamino)pentan-1-one ("pentylone"); 592
(vii) 4-fluoro-N-methylcathinone ("4-FMC"); 593
(viii) 3-fluoro-N-methylcathinone ("3-FMC"); 594
(ix) 1-(naphthalen-2-yl)-2- (pyrrolidin-1-yl) 595
pentan-1-one ("naphyrone"); 596
(x) Alpha-pyrrolidinobutiophenone ("α-PBP"); 597
(xi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino) 598
-pentan-1-one (N-ethylpentylone, ephylone); 599
(14) a-PiHP 600
4-methyl-1-phenyl-2-pyrrolidin-1-yl)pentan-1-one, also known as 601
alpha-PiHP; * * * 602
(15) 3–MMC 603
2-methylamino)-1-3-methylphenyl)propan-1-one, also known as 604
3-methylmethcathinone * * *; and 605
(16) ethyl 2-phenyl-2-piperidin-2-yl)acetate). 606
SECTION 2. This act shall take effect and be in force from 607
and after July 1, 2026. 608